维普中文期刊产品整合服务

Prediction of HLA-A 2.1-restricted CTL epitopes from IGFBP7 antigen of lung carcinoma

查看全文 作  者:Zhao [1]Weipeng;Long [2]Haixia;Zhu [1]Bo;Duan [1]Yuzhong;Chen [1]Zhengtang 高影响力作者 机构地区:[1]Cancer Research Center, Xinqiao Hospital Third Military Medical University, Chongqing 400037, China;[2]School of Bioengineering, Chongqing lnstitute of Technology, Chongqing 400050, China高影响力机构 出  处:《Journal of Medical Colleges of PLA(China)》索引2009年第24卷第2期,共6页高影响力期刊 基  金:Supported by the Special fund of the National High Technology Research and Development Program of China (863 Program,2007AA02Z129);the National Natural Science Foundation of China (30672076 and 30800506) 摘  要:Objective:With the development of peptide-based cancer specific immunotherapy,the prediction of CTL epitopes from insulin-like growth factor-binding protein 7(IGFBP7) is very important for some research about tumor metastasis.Because HLA-A2.1-expressing individuals cover >50% in the population of China,we aimed at identifying IGFBP7-encoded peptide presented by HLA-A2.1.Methods:In our study,a HLA-A2.1 restricted CTL epitope was identified by using the following two-step procedure:(a) computer-based epitope prediction from the amino acid sequence of IGFBP7 antigen;(b) Validation with epitope molecular modeling.Results:We obtained four epitopes with high immunogenicity scores by all of the three algorithms,i.e.,BIMAS,SYFPEITHI and IMTECH.Each of the four candidates satisfied the criteria of the HLA-A2.1-restricted CTL epitopes in molecular modeling analysis.Conclusion:The combination of BIMAS,SYFPEITHI and IMTECH method can improve the prediction efficiency and accuracy.Due to this research herein,this four epitopes have potential value for further studied,also have potential application in peptide-mediated immunotherapy.These epitopes may be useful in the design of therapeutic peptide vaccine for lung carcinoma and as immunotherapeutic strategies against lung carcinoma after identified by immunology experiment. 关 键 词:表位抗原 表位预测 限制性CTL 肺癌 胰岛素样生长因子结合蛋白 人类白细胞抗原 特异性免疫治疗 HLA
相关文献

参考文献(11)

引证文献(1)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费